跳至主要内容
临床试验/NCT03303430
NCT03303430Unknown不适用

Correlation Between Cerebral Microembolisation and Plaque Characteristics After Carotid Revascularization

University Hospital, Geneva1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2017年3月30日最近更新:
适应症

试验速览

阶段
不适用
入组人数
120
试验地点
1
主要终点
Cerebral microembolisation

研究概览

简要总结

Microembolisation identified on diffusion-weighted magnetic resonance imaging (DW-MRI) is recognized as an important outcome measure for carotid revascularization procedures such as carotid stenting (CAS) or carotid endarterectomy (CEA). In fact, cerebral microembolisation occurring during revascularization procedures is associated with an increased risk of peri- and post-procedural stroke, transient ischemic attack as well as neurocognitive decline. Carotid artery stenting is a less invasive alternative to endarterectomy to treat symptomatic or asymptomatic carotid stenosis. Large randomized clinical trials showed a higher periprocedural risk of non-disabling stroke with CAS and a higher periprocedural risk of myocardial infarction, cranial nerve palsy, and access site hematoma with CEA.

However little is known regarding the correlation between the morphological characteristics of the carotid plaque and the occurrence of microembolisation during the procedure and between microembolisation and midterm cognitive impairment. A few studies suggest that plaque morphology may be an important determinant for the increased risk of microembolisation. These studies however have mainly investigated microembolisation occurring during CAS and exploratory studies comparing the two procedures are still lacking.

The purpose of the present study is to determine the correlation between the morphological characteristics of the carotid plaque and cerebral microembolisation either after carotid stenting or after carotid endarterectomy in patients with symptomatic or asymptomatic carotid disease.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients presenting a symptomatic (ipsilateral ischemic stroke, TIA located in the carotid artery territory or retinal ischemia) carotid stenosis between 50% and 99% (according to NASCET and ECST criteria)
  • Patients presenting an asymptomatic carotid stenosis between 60% and 99% (according to NASCET and ECST criteria) Patients who accept the informed consent

排除标准

  • Important neurological deficit with NIHSS >7 (or severe aphasia) at time of inclusion
  • Previous known cognitive impairment
  • Pregnancy
  • Presence of contraindication based on ground of multidisciplinary team decision:
  • For surgery:
  • High bifurcation Intracranial extension of the carotid stenosis Patients with tandem lesions High suspicion of severe siphon stenosis Patients with previous irradiation of the cervical region Patients with restenosis after endarterectomy
  • For stenting; Excessive arch vessel or carotid artery tortuosity and in particular presence tortuosity ≤90 degrees in the cervical segment Excessive aortic arch plaque burden Patients older than 70 years Unfavourable anatomic disposition as described above Co-morbidities that may preclude the use of a periprocedural dual antiplatelet regime.
  • For CT-scan Iodine allergy Renal insufficiency
  • For MRI Pacemaker Any other metallic implants Claustrophobia
  • For ultrasound Bad quality ultrasound (patient morphology or equipments

结局指标

主要结局

Cerebral microembolisation

时间窗: 24 hours

the presence of at least 1 new hyperintense DWI lesion on the MRI realized within the 24 hours after procedure and will be correlated to the different characteristics of the carotid plaque evaluation.

次要结局

  • Neuropsychological assessment(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Loraine Fisch

Principal investigator

University Hospital, Geneva

研究点 (1)

Loading locations...

相似试验

Microembolisation After Carotid Revascularisation | 临床试验